Produkty 95815-58-0

CAS 95815-58-0 występuje w naszej ofercie pod nazwami: Prednisolone EP Impurity E (14-Alpha-hydroxy Prednisolone), Prednisolone EP Impurity E, Prednisolone Impurity 5（Prednisolone EP Impurity E）. Oferty producentów: Chemat Brand, Hubei YoungXin. Dostępne opakowania: on request, 10mg, 25mg, 50mg, 100mg, 200mg.

Prednisolone EP Impurity E (14-Alpha-hydroxy Prednisolone)
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Prednisolone EP Impurity E
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Prednisolone Impurity 5（Prednisolone EP Impurity E）
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(8R,9S,10R,11S,13S,14R,17R)-11,14,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-3-one (CAS 95815-58-0) to związek chemiczny o wzorze sumarycznym C21H28O6 i masie molowej 376.4 g/mol. Nazwa systematyczna IUPAC: (8R,9S,10R,11S,13S,14R,17R)-11,14,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-3-one. InChIKey: USJJKJYVBSEDNP-CNPAUTQISA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H28O6
Masa molowa376.4 g/mol
Nazwa IUPAC(8R,9S,10R,11S,13S,14R,17R)-11,14,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-3-one
InChIKeyUSJJKJYVBSEDNP-CNPAUTQISA-N
SMILESC[C@]12C[C@@H]([C@H]3[C@H]([C@@]1(CC[C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@]34C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Prednisolone EP Impurity E, 14alpha-Hydroxyprednisolone, Prednisolone impurity E [EP], PREDNISOLONE IMPURITY E [EP IMPURITY], 11beta,14,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione, (11beta)-11,14,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione, 11beta,14alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione
Izomery (ten sam wzór sumaryczny)
(8S,9S,10R,11R,13S,14S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C21H28O6
(8S,9S,10R,11S,13S,14S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C21H28O6
(6R,8S,9S,10R,11S,13S,14S,17R)-6,11,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C21H28O6
(6R,8S,9S,10R,13S,14S,17R)-6,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,11-dione C21H28O6
(6S,8S,9S,10R,13S,14S,17R)-6,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,11-dione C21H28O6
(8S,9S,10R,11S,13R,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10-methyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-13-carbaldehyde C21H28O6
2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoacetic acid C21H28O6
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,7,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,6-dione C21H28O6
3-[4-[2-[4-(2,3-dihydroxypropoxy)phenyl]propan-2-yl]phenoxy]propane-1,2-diol C21H28O6